Literature DB >> 22506947

Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.

Paula Tanabe1, John W Hafner, Zoran Martinovich, Nicole Artz.   

Abstract

OBJECTIVES: The aims of this study were to 1) estimate differences in pain management process and patient-reported outcomes, pre- and postimplementation of analgesic protocols for adults with sickle cell disease (SCD), and 2) examine the effects of site and visit frequency on changes in pain scores and time to analgesic.
METHODS: A multicenter, prospective, longitudinal study enrolled patients from three academic medical centers between October 2007 and September 2009. All ED patients 18 years or older with a chief complaint of a sickle cell pain episode were enrolled. Sites formed a SCD quality improvement (QI) team and implemented standard nurse-initiated emergency department (ED) analgesic protocols; outcomes were compared between study periods defined as pre- and postimplementation of protocols. Medical record review was conducted to measure time to administration of initial analgesic, opioids used, route of opioid administration, the change in pain scores from arrival to discharge (negative numbers reflect a decrease in pain scores), and the number of ED visits per individual patient during the study period at each site. On day 7 after the ED visit, a follow-up phone interview was conducted. Patients were queried about their ED pain management using a scale from 1 to 10 (1 = outstanding, 10 = worst). Descriptive statistics are used to report the results. Ordinary least-squares regression models were constructed to measure the effect of time period, site, and number of visits per patient on change in pain score.
RESULTS: During the study period, 342 unique patients (57% female, mean ± SD age = 32 ± 11 years) were enrolled and had a total of 2,934 visits. There was no difference in time to administration of the initial analgesic between study periods. Overall, there was a significant decrease in pain scores from arrival to discharge between the pre- and postintervention study periods: the average difference in arrival to discharge pain scores (cm) was greater during the postimplementation period than during the preintervention period (-4.1 vs. -3.6, t = 2.6, p < 0.01). Site 1 had significant improvement between study periods (mean difference = -0.87, t = 2.63, p < 0.01; F = 14.3, p < 0.01). Patients with few ED visits (one to six annual visits, mean difference = -1.55, t = 2.1, p = 0.04) and those with frequent ED visits (7 to 19 annual visits, mean difference = -1.65, t = 3.52, p < 0.01) had a significant decrease in pain scores compared to patients with very frequent ED visits (>19 visits). There was an overall decrease in the use of morphine sulfate (MS) and increase in the use of hydromorphone (χ(2) = 105.67, p < 0.001) between study periods and a significant increase in the use of oral (PO) and subcutaneous (SC) routes, with a corresponding decrease in the intravenous (IV) route (χ(2) = 13.67, p < 0.001). There were no statistically significant differences in patient-reported satisfaction with the attempt to manage pain in the ED between study periods (p = 0.54).
CONCLUSIONS: While the use of a learning collaborative and implementation of nurse-initiated analgesic protocols was not associated with improvement in time to administration of the initial analgesic, improvements in the decrease in the arrival to discharge pain score and increased use of hydromorphone and the SC route were noted in adults with SCD in the ED.
© 2012 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22506947      PMCID: PMC3691105          DOI: 10.1111/j.1553-2712.2012.01330.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  19 in total

1.  Factors associated with delay to opiate analgesia in emergency departments.

Authors:  Glenn Arendts; Margaret Fry
Journal:  J Pain       Date:  2006-09       Impact factor: 5.820

2.  A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic.

Authors:  Matthew P Lazio; Heather H Costello; D Mark Courtney; Zoran Martinovich; Randall Myers; Amy Zosel; Paula Tanabe
Journal:  Clin J Pain       Date:  2010 Mar-Apr       Impact factor: 3.442

Review 3.  Emergency management of sickle cell disease complications: review and practice guidelines.

Authors:  John L Hick; Stephen C Nelson; Karen Hick; M Obinna Nwaneri
Journal:  Minn Med       Date:  2006-02

4.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

5.  The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.

Authors:  Sophie Lanzkron; C Patrick Carroll; Carlton Haywood
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

6.  Emergency department management of acute pain episodes in sickle cell disease.

Authors:  Paula Tanabe; Randall Myers; Amy Zosel; Jane Brice; Altaf H Ansari; Julia Evans; Zoran Martinovich; Knox H Todd; Judith A Paice
Journal:  Acad Emerg Med       Date:  2007-03-26       Impact factor: 3.451

7.  Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease.

Authors:  Melissa J Frei-Jones; Joshua J Field; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

8.  Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.

Authors:  Melissa Givens; Cynthia Rutherford; Girish Joshi; Kathleen Delaney
Journal:  J Emerg Med       Date:  2007-02-07       Impact factor: 1.484

9.  Comparisons of high versus low emergency department utilizers in sickle cell disease.

Authors:  Imoigele P Aisiku; Wally R Smith; Donna K McClish; James L Levenson; Lynne T Penberthy; Susan D Roseff; Viktor E Bovbjerg; John D Roberts
Journal:  Ann Emerg Med       Date:  2008-10-16       Impact factor: 5.721

10.  The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.

Authors:  C Patrick Carroll; Carlton Haywood; Peter Fagan; Sophie Lanzkron
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

View more
  16 in total

Review 1.  Improving Emergency Department-Based Care of Sickle Cell Pain.

Authors:  Jeffrey A Glassberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 2.  Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease.

Authors:  Paul Telfer; Banu Kaya
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis.

Authors:  Ali Pourmand; Gregory Jasani; Courtney Shay; Maryann Mazer-Amirshahi
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

4.  The impact of race and disease on sickle cell patient wait times in the emergency department.

Authors:  Carlton Haywood; Paula Tanabe; Rakhi Naik; Mary Catherine Beach; Sophie Lanzkron
Journal:  Am J Emerg Med       Date:  2013-02-04       Impact factor: 2.469

Review 5.  Key Components of Pain Management for Children and Adults with Sickle Cell Disease.

Authors:  Amanda M Brandow; Michael R DeBaun
Journal:  Hematol Oncol Clin North Am       Date:  2018-06       Impact factor: 3.722

6.  Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.

Authors:  Jeffrey Glassberg; Jena Simon; Nilesh Patel; Jordan M Jeong; Justin J McNamee; Gary Yu
Journal:  Am J Emerg Med       Date:  2015-07-17       Impact factor: 2.469

7.  A Quality Improvement Initiative to Improve Emergency Department Care for Pediatric Patients with Sickle Cell Disease.

Authors:  Marsha J Treadwell; Michael Bell; Sara A Leibovich; Fernando Barreda; Anne Marsh; Ginny Gildengorin; Claudia R Morris
Journal:  J Clin Outcomes Manag       Date:  2014-02

8.  Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use.

Authors:  Nancy Crego; Christian Douglas; Emily Bonnabeau; Marian Earls; Kern Eason; Elizabeth Merwin; Gary Rains; Paula Tanabe; Nirmish Shah
Journal:  J Am Board Fam Med       Date:  2020 Jan-Feb       Impact factor: 2.657

9.  Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.

Authors:  Tess E Cooper; Ian R Hambleton; Samir K Ballas; Brydee A Johnston; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-14

10.  A prospective study to compare serial changes in pain scores for patients with and without a history of frequent ED utilization.

Authors:  Ryan Joseph; Alainya Tomanec; Thomas McLaughlin; Jose Guardiola; Peter Richman
Journal:  Heliyon       Date:  2021-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.